US Patent Issued to TAKIS on July 7 for "Polynucleotides encoding SARS-COV-2 antigens and use thereof in the medical field as vaccines" (Italian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,095, issued on July 7, was assigned to TAKIS S.R.L. (Rome).

"Polynucleotides encoding SARS-COV-2 antigens and use thereof in the medical field as vaccines" was invented by Luigi Aurisicchio (Rome), Emanuele Marra (Rome), Giuseppe Roscilli (Rome), Fabio Palombo (Rome), Mariano Maffei (Rome) and Alessia Muzi (Rome).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to polynucleotides encoding antigens of the SARS-CoV-2 coronavirus spike protein and use thereof in the medical field as vaccines for the prevention and treatment of COVID-19 infection."

The patent was filed on April 30, 2021, under Application No. 17/997,527.

*For...